NCT Number: NCT03332654
Stress Urinary Incontinence in Women With Multiple Sclerosis
Objective: To report the prevalence and risk factors of stress urinary incontinence (SUI) and the prevalence of intrinsic sphincter deficiency in women with multiple sclerosis (MS). Methods: A retrospective study was conducted among Female patients with MS, followed for lower urinary tract symptoms (LUTS) during a 15-year period. Demographic data, MS history, expanded disability status scale (EDSS) score at the urodynamic visit, obstetrical past, birth weight, LUTS, and urodynamic findings were collected. SUI was defined as incontinence during cough, or any effort. A maximum urethral closure pressure less than 30 cm H2O defined intrinsic sphincter deficiency. Results: In total 363 women with a mean age of 46.7±10.8 years and a mean disease duration of 12.9±8.7 years were included. The incidence of relapsing remitting MS, a secondary progressive form, and a primary progressive form was 60.6%, 32.8%, and 6.6%, respectively. The prevalence of SUI was 31.4%. The prevalence of intrinsic sphincter deficiency was 1.4% and 0.8% of these patients had a SUI (P=0.300). In a multivariate analysis, women with a SUI had significantly higher birth weight (P=0.030), a pelvic organ prolapse (P=0.021), urgent urinary incontinence (P=0.006), a lower EDSS score (P=0.019), and a weaker containing effort (P<0.001). Conclusions: The prevalence of SUI in women with MS was 31.4%. This symptom could affect the quality of life of women with MS.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
Female
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Women aged >18 years
- Multiple sclerosis
- Urodynamic test for lower urinary tract symptoms
- Followed in Saint Philibert Hospital between December 1999 to June 2014
Exclusion criteria
- Non confirmation of diagnosis of Multiple sclerosis
Treatment and study plan
Primary outcomes
-
Stress urinary incontinence
Time frame: at inclusion
Sponsors and collaborators
Lead sponsor
Lille Catholic University
Other
Registry information
Official study title
Prevalence and Risk Factors of Stress Urinary Incontinence in Women With Multiple Sclerosis
Acronym: UROSEP
Important dates
- Study start
- 2015
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Nov 6, 2017
- Registry last updated
- Nov 6, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD
NCT04114266
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ghent, Belgium
View Trial DetailsCan Women Correctly Contract Their Pelvic Floor Muscles After to Receive Verbal Instructions and Vaginal Palpation?
NCT03325543
Behavior, Female Urogenital Diseases
São Paulo, Brazil
View Trial DetailsDo Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?
NCT02540798
Anxiety, Anxiety Disorders
Birmingham, United Kingdom
View Trial DetailsSling vs Botox for Mixed Incontinence
NCT04171531
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Birmingham, Alabama, United States
View Trial Details